Researchers supported by the National Institutes of Health have found that dual bronchodilators – long-lasting inhalers that relax the airways and make it easier to breathe – do little to help people ...

To assess the risk of pneumonia among COPD patients using salmeterol/fluticasone-piopionate combination inhalers (SFC), inhaled corticosteroids (ICS), or long-acting beta-agonists (LABA), alone or in ...

Chronic obstructive pulmonary disease (COPD) medications can help you breathe more easily and improve your quality of life. You take some types every day, but you use others for quick relief only when ...

Researchers have found that dual bronchodilators -- long-lasting inhalers that relax the airways and make it easier to breathe -- do little to help people who do not have chronic obstructive pulmonary ...

Researchers find a 28 percent greater risk of heart attack and stroke in older patients taking commonly prescribed drugs for chronic obstructive pulmonary disease (COPD). Canadian scientists are ...

Fixed long-acting combinations of both anticholinergic and beta-agonist bronchodilators, not previously available, have been developed. A new fixed combination of glycopyrronium and indacaterol has ...

Please provide your email address to receive an email when new articles are posted on . Inhaled dual bronchodilator therapy did not decrease respiratory symptoms among individuals who were current or ...

Dual bronchodilators – long-lasting inhalers that relax the airways do little to help individuals who do not have chronic obstructive pulmonary disease (COPD). Dual bronchodilators – long-lasting ...

OBSTRUCTIVE pulmonary emphysema, as the term is used here, refers to a chronic progressive process manifested clinically by dyspnea, which most commonly makes its appearance in middle-aged or elderly ...